+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Arthritis Drug"

From
From
Arthritis (Musculoskeletal) - Drugs in Development, 2021 - Product Thumbnail Image

Arthritis (Musculoskeletal) - Drugs in Development, 2021

  • Report
  • April 2021
  • 105 Pages
  • Global
From
From
Gouty Arthritis (Gout) - Pipeline Review, H2 2020 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 139 Pages
  • Global
From
Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2019 - Product Thumbnail Image

Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 58 Pages
  • Global
From
Arthritis Treatment Drugs Companies in China - Product Thumbnail Image

Arthritis Treatment Drugs Companies in China

  • Report
  • July 2023
  • 84 Pages
  • China
From
Arthritis Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Arthritis Treatment Drugs Industry Forecasts - China Focus

  • Report
  • July 2023
  • 104 Pages
  • China
From
From
From
From
From
Loading Indicator

The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease. The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more